Raul Cordoba Shared a Study Comparing Two CAR T-cell Therapies Over 3 years in B-cell Lymphoma
Raul Cordoba, Head of the Lymphoma Unit at the Foundation Jimenez Diaz University Hospital, shared a post on X:
“Real-world comparison RWE of CARTcell lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow-up.”
Title: Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow-up
Authors: Andrew J. Portuguese, Jennifer J. Huang, Yein Jeon, Mahnoosh Taheri, Aya Albittar, Emily C. Liang, Alexandre V. Hirayama, Erik L. Kimble, Lorenzo Iovino, Christina Poh, Ajay K. Gopal, Mazyar Shadman, Brian G. Till, Filippo Milano, Aude G. Chapuis, Folashade Otegbeye, Ryan D. Cassaday, Ryan S. Basom, Qian Vicky Wu, David G. Maloney, Jordan Gauthier
Read the Full Article.
More posts featuring Raul Cordoba.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023